QSAM Biosciences's market cap is currently ―. The company's EPS TTM is $-1.719; its P/E ratio is -4.68; QSAM Biosciences is scheduled to report earnings on May 14, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ -5.18K	$ -7.31K	$ -43.12K	$ -370.48K	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	-	-	$ -1.51M	$ -1.18M	$ -1.21M
EBITDA	-	-	$ -1.47M	$ -1.17M	$ -1.21M
Net Income Common Stockholders	$ -1.25M	$ -1.28M	$ 438.28K	$ -4.75M	$ -1.28M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 899.29K
Total Assets	$ 610.32K	$ 462.61K	$ 1.29M	$ 364.62K	$ 965.45K
Total Debt	$ 0.00	$ 0.00	$ 7.50K	$ 443.70K	$ 567.13K
Net Debt	$ 0.00	$ 0.00	$ 7.50K	$ 443.70K	$ -332.17K
Total Liabilities	$ 1.71M	$ 1.38M	$ 1.30M	$ 1.58M	$ 2.66M
Stockholders Equity	$ -1.84M	$ -1.65M	$ -735.26K	$ -1.94M	$ -1.70M
Cash Flow	-
Free Cash Flow	$ -443.10K	$ -804.37K	$ -440.46K	$ -1.15M	$ -455.06K
Operating Cash Flow	$ -443.10K	$ -804.37K	$ -440.46K	$ -1.15M	$ -455.06K
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	$ 500.00K	$ 342.67K	$ 1.07M	$ 477.50K	$ 925.00K

Currency in USD

QSAM Biosciences Earnings and Revenue History

Income Statement >

QSAM Biosciences Debt to Assets

Balance Sheet >

QSAM Biosciences Cash Flow

Cash Flow >

QSAM Biosciences Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing